Endometrial Cancer is a common type of gynecologic malignancy that develops in the lining of the uterus, known as the endometrium. It typically occurs when abnormal cells grow uncontrollably in the uterine lining, forming malignant tumors that may spread to nearby tissues if untreated. Research in Endometrial Cancer focuses on identifying hormonal, genetic, and environmental factors that contribute to tumor development while advancing early detection methods and targeted treatment strategies.

At global scientific gatherings such as an Oncology Conference, experts frequently discuss emerging diagnostic tools, molecular insights, and therapeutic innovations related to uterine malignancies. Endometrial cancer is one of the most frequently diagnosed cancers in women and often presents with symptoms at early stages, allowing timely diagnosis and treatment. A closely related term widely used in medical literature is Uterine Cancer, which broadly refers to cancers that develop in the uterus, including endometrial malignancies.

Hormonal imbalance is one of the primary factors associated with the development of endometrial cancer. Excess estrogen without adequate progesterone regulation can stimulate abnormal growth in the uterine lining. This imbalance may occur due to obesity, hormonal therapy, polycystic ovary syndrome, or certain metabolic conditions.

Most patients with endometrial cancer experience abnormal uterine bleeding, particularly after menopause. Other symptoms may include pelvic discomfort, unusual vaginal discharge, or pain during urination. Because these symptoms often appear early, many cases are diagnosed before the disease spreads beyond the uterus.

Diagnosis typically begins with imaging and tissue sampling procedures. Transvaginal ultrasound is commonly used to evaluate the thickness of the endometrial lining, while endometrial biopsy confirms the presence of cancer cells through microscopic examination.

Molecular and genetic studies have also improved the understanding of endometrial cancer development. Mutations in genes involved in cell growth and DNA repair may contribute to tumor formation and progression. These discoveries have helped researchers classify endometrial tumors into distinct molecular subtypes.

Surgery is usually the primary treatment for endometrial cancer. The standard procedure involves removal of the uterus and, in many cases, the ovaries and fallopian tubes. This approach effectively removes the tumor and reduces the risk of recurrence.

Radiation therapy and chemotherapy may be recommended for patients with advanced or high-risk disease. These treatments help eliminate remaining cancer cells and prevent disease progression.

Targeted therapies and immunotherapies are also being studied for the treatment of advanced endometrial cancer. Drugs targeting specific molecular pathways involved in tumor growth may provide new options for patients whose cancer does not respond to conventional treatments.

Researchers continue to explore preventive strategies, including lifestyle modifications and screening approaches for high-risk populations. Advances in precision medicine and molecular diagnostics are helping clinicians develop more personalized treatment plans for patients with endometrial cancer.